Journal
CURRENT PHARMACEUTICAL DESIGN
Volume 20, Issue 28, Pages 4580-4588Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612820666140522115801
Keywords
MCP-1; CCL2; CCLR2; atherosclerosis and chemokine
Categories
Funding
- Trustees of the Thrombosis Research Institutes in London
- Garfield Weston Foundation, UK
- National Natural Science Foundation of China [31000475]
Ask authors/readers for more resources
Monocyte chemotactic protein-1 (MCP-1) (also referred to as chemokine (C-C motif) ligand 2 (CCL2) is expressed by mainly inflammatory cells and endothelial cells. The expression level is upregulated after proinflammatory stimuli and tissue injury which are associated with atherosclerotic lesion. Atherosclerosis is a progressive disease starting with accumulation of lipids, lipoproteins, and immune cells in the arterial wall. MCP-1 has been reported to play an important role in the pathogenesis of atherosclerosis and considerable evidence supports that the monocyte containing MCPs and macrophage influences the growth of other cell types within the atherosclerotic lesion. This review will focus on the general structure features of MCP-1 and its role in atherosclerosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available